PMID- 18206999 OWN - NLM STAT- MEDLINE DCOM- 20080422 LR - 20131121 IS - 1873-4324 (Electronic) IS - 0003-2670 (Linking) VI - 608 IP - 1 DP - 2008 Feb 4 TI - Development of an on-site screening system for amphetamine-type stimulant tablets with a portable attenuated total reflection Fourier transform infrared spectrometer. PG - 95-103 LID - 10.1016/j.aca.2007.12.002 [doi] AB - We tried to develop a library search system using a portable, attenuated total reflection Fourier transform infrared (ATR-FT-IR) spectrometer for on-site identification of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) tablets. The library consisted of the spectra from mixtures of controlled drugs (e.g. MDMA and ketamine), adulterants (e.g. caffeine), and diluents (e.g. lactose). In the seven library search algorithms, the derivative correlation coefficient showed the best discriminant capability. This was enhanced by segmentation of the search area. The optimized search algorithm was validated by the positive (n=154, e.g. the standard mixtures containing the controlled drug, and the MDMA/MDA tablets confiscated) and negative samples (n=56, e.g. medicinal tablets). All validation samples except for four were judged truly. Final criteria for positive identification were decided on the basis of the results of the validation. In conclusion, a portable ATR-FT-IR spectrometer with our library search system would be a useful tool for on-site identification of amphetamine-type stimulant tablets. FAU - Tsujikawa, Kenji AU - Tsujikawa K AD - National Research Institute of Police Science, 6-3-1, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan. tujikawa@nrips.go.jp FAU - Kuwayama, Kenji AU - Kuwayama K FAU - Miyaguchi, Hajime AU - Miyaguchi H FAU - Kanamori, Tatsuyuki AU - Kanamori T FAU - Iwata, Yuko T AU - Iwata YT FAU - Yoshida, Takemi AU - Yoshida T FAU - Inoue, Hiroyuki AU - Inoue H LA - eng PT - Journal Article DEP - 20071208 PL - Netherlands TA - Anal Chim Acta JT - Analytica chimica acta JID - 0370534 RN - 0 (Amphetamines) RN - 0 (Tablets) RN - 3G6A5W338E (Caffeine) RN - 4764-17-4 (3,4-Methylenedioxyamphetamine) RN - 690G0D6V8H (Ketamine) RN - J2B2A4N98G (Lactose) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - 3,4-Methylenedioxyamphetamine/*analysis MH - Algorithms MH - Amphetamines/*analysis MH - Caffeine/analysis MH - Chemistry, Pharmaceutical/*methods MH - Drug Evaluation, Preclinical MH - Equipment Design MH - Ketamine/analysis MH - Lactose/analysis MH - N-Methyl-3,4-methylenedioxyamphetamine/*analysis MH - Software MH - Spectroscopy, Fourier Transform Infrared/*instrumentation/*methods MH - Substance Abuse Detection/*instrumentation/methods MH - Tablets EDAT- 2008/01/22 09:00 MHDA- 2008/04/23 09:00 CRDT- 2008/01/22 09:00 PHST- 2007/07/02 00:00 [received] PHST- 2007/11/15 00:00 [revised] PHST- 2007/12/03 00:00 [accepted] PHST- 2008/01/22 09:00 [pubmed] PHST- 2008/04/23 09:00 [medline] PHST- 2008/01/22 09:00 [entrez] AID - S0003-2670(07)01965-4 [pii] AID - 10.1016/j.aca.2007.12.002 [doi] PST - ppublish SO - Anal Chim Acta. 2008 Feb 4;608(1):95-103. doi: 10.1016/j.aca.2007.12.002. Epub 2007 Dec 8.